Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date.

This publication has 24 references indexed in Scilit:

• Effect of Risedronate on the Risk of Hip Fracture in Elderly Women
  New England Journal of Medicine, 2001
• Risk of Mortality Following Clinical Fractures
  Osteoporosis International, 2000
• Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis
  Journal of Bone and Mineral Research, 2000
• Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis
  Osteoporosis International, 2000
• Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral FracturesResults From the Fracture Intervention Trial
  JAMA, 1998
• Calcium for Prevention of Osteoporotic Fractures in Postmenopausal Women
  Journal of Bone and Mineral Research, 1997
• Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
  New England Journal of Medicine, 1995
• Vitamin D₃and Calcium to Prevent Hip Fractures in Elderly Women
  New England Journal of Medicine, 1992
• Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis
  New England Journal of Medicine, 1990
• Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal Osteoporosis
  New England Journal of Medicine, 1990